<code id='50062A1D93'></code><style id='50062A1D93'></style>
    • <acronym id='50062A1D93'></acronym>
      <center id='50062A1D93'><center id='50062A1D93'><tfoot id='50062A1D93'></tfoot></center><abbr id='50062A1D93'><dir id='50062A1D93'><tfoot id='50062A1D93'></tfoot><noframes id='50062A1D93'>

    • <optgroup id='50062A1D93'><strike id='50062A1D93'><sup id='50062A1D93'></sup></strike><code id='50062A1D93'></code></optgroup>
        1. <b id='50062A1D93'><label id='50062A1D93'><select id='50062A1D93'><dt id='50062A1D93'><span id='50062A1D93'></span></dt></select></label></b><u id='50062A1D93'></u>
          <i id='50062A1D93'><strike id='50062A1D93'><tt id='50062A1D93'><pre id='50062A1D93'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:hotspot    Page View:853
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In
          Previous article: FDA advisers back CAR
          Next article: Alkermes shareholders re

          comprehensive

          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more
          Medicare Advantage insurers pressure Biden for bigger payments
          Medicare Advantage insurers pressure Biden for bigger payments

          AdobeThepublicwillsoonfindoutwhetherthefederalgovernmentiswillingtomeetthehealthinsuranceindustry’sd

          read more
          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more

          Ebola: Gilead Sciences antiviral shows promise as new treatment

          UgandamedicalstaffatanEbolatreatmentcenterinthetownofMubende.BADRUKATUMBA/AFPviaGettyImagesAnewstudy